摘要
摘要目的分析蛛网膜下腔出血患者借助尼莫地平、阿托伐他汀钙联合疗法预防脑血管痉挛的临床效果.方法将我院２０１１年５月－２０１４年１１月所挑选蛛网膜下腔出血患者６０例作为对象实验、研究,分成不同临床疗法组,如对照组行尼莫地平疗法,研究组行尼莫地平＋阿托伐他汀钙疗法,评估临床效果.结果研究组患者临床预后脑血管痉挛发生率６．７％低于对照组３０．０％,存在差异(P＜０．０５).结论临床借助尼莫地平、阿托伐他汀钙联合疗法治疗蛛网膜下腔出血患者作用显著,可预防脑血管痉挛症状,降低不良反应,值得学习.关键词尼莫地平;阿托伐他汀钙;蛛网膜下腔出血;脑血管痉挛NimhorizonjointatorvastatincalciumtopreventcerebralvasospasmaftersubarachnoidhemorrhageAbstractObjectivetoanalyzepatientswithsubarachnoidhemorrhagewiththehelpofnimhorizon,atorvastatincalciumclinicaleffectofcombinationtherapytopreventcerebralvasospasm．MethodsfromMay２０１１toNovember２０１４selected６０patientswithsubarachnoidhemorrhageasexperimentalobject,theresearchandclinicaltherapyweredividedintodifferentgroups,suchasthecontrollinenimntherapy,theteamlinenimhorizon＋atorvastatincalciumtherapy,toevaluatetheclinicaleffect．Resultsclinicaloutcomesforpatientswithteamcerebralvasospasmincidence６．７％lowerthanthecontrolgroup３０．０％,therearedifferences(P＜０．０５)．Conclusiontheclinicalusingnimhorizon,atorvastatincalciumcombinationtherapyinthetreatmentofsubarachnoidhemorrhagepatientseffectsignificantly,canpreventcerebrovascularspasmsymptoms,reduceKaedyvewrosredrseactions,worthlearning．nimhorizon;Atorvastatincalcium;Subarachnoidhemorrhage．Cerebralvasospasm中图分类号R９１７文献标识码B文章编号１００８－６３１５(２０１５)１２－０２７７－０２
出版日期
2015年12月22日（中国Betway体育网页登陆平台首次上网日期，不代表论文的发表时间）
